Interval carcinomas of the breast: a group with intermediate outcome

Journal of Surgical Oncology
A A SchroënR F van der Sluis

Abstract

Interval carcinoma is defined as a carcinoma detected between two mammographic screening rounds after a negative screening. By some authors these carcinomas are considered to be more aggressive than screen-detected carcinomas. In a group of 937 patients referred for breast cancer in the period 1975-1990, 76 interval carcinoma patients were treated. In a retrospective study the outcome was studied of patients with an interval carcinoma in comparison with patients with screen-detected carcinomas and of patients with clinically detected carcinomas outside the screening program. No significant difference was found in the 5-year and 10-year disease-free survival of patients with interval carcinoma (80%, 68%) and the screen-detected group (89%, 81%) (P = 0.12). The interval group did significantly better than the patients with carcinomas detected outside the screening program (P = 0.03). Interval-detected cancers for patients in the screening program had an outcome intermediate between patients with screen-detected cancers and patients with cancers detected outside the screening program. The difference between interval-detected cancers and cancers detected outside the screening program was significant, whereas the difference between ...Continue Reading

References

Feb 22, 1992·BMJ : British Medical Journal·P J KlemiI Parvinen
Jan 1, 1985·Breast Cancer Research and Treatment·A von RosenG Auer
Nov 15, 1988·International Journal of Cancer. Journal International Du Cancer·O P KallioniemiM Hakama
Jan 1, 1987·Breast Cancer Research and Treatment·J FrisellA Somell
Jul 1, 1993·The British Journal of Surgery·W J CrispJ R Young

❮ Previous
Next ❯

Citations

Jan 25, 2014·Clinical Radiology·Y FongK Gower Thomas
Apr 18, 2014·SpringerPlus·Amalia PlotogeaUNKNOWN Breast Screening Study Group
Apr 18, 2000·Journal of Clinical Pathology·W K CowanS R al-Tamimi
Nov 1, 2015·Breast Cancer Research and Treatment·Anna M ChiarelliMartin J Yaffe
Feb 18, 2004·The Breast : Official Journal of the European Society of Mastology·M A RajaA R Salman
Feb 1, 2003·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·R P R GroenendijkT Wobbes
Jul 10, 2016·Breast Cancer Research and Treatment·Roy J P WeberLucien E M Duijm
Sep 2, 2009·Journal of the National Cancer Institute·Anna M ChiarelliVerna Mai
Feb 26, 2011·Journal of the National Cancer Institute·Stella MookMarjanka K Schmidt
May 5, 2011·Journal of the National Cancer Institute·Victoria A KirshNorman F Boyd
May 16, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Antonino MusolinoAndrea Ardizzoni
Oct 28, 2010·Cancer Causes & Control : CCC·Jan T LoweryJudy Mouchawar
Jan 26, 2000·British Journal of Cancer·R P GroenendijkT Wobbes
Dec 21, 2016·Cancer Causes & Control : CCC·Solenne Delacour-BillonFlorence Molinié
Apr 8, 1998·The British Journal of Surgery·A M SchroënR F van der Sluis

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.